RecruitingNot ApplicableNCT07062770

Assessment of Circuit Rebreathing During CPAP Therapy

Assessment of Circuit Rebreathing During Continuous Positive Airway Pressure (CPAP) Therapy


Sponsor

Brigham and Women's Hospital

Enrollment

13 participants

Start Date

May 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).


Eligibility

Min Age: 21 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Continuous positive airway pressure (CPAP) and Mask exhaust port flow for people with obstructive sleep apnea (osa). The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContinuous positive airway pressure (CPAP)

Subjects will be administered either 0, 5 or 10 cmH2O

OTHERMask exhaust port flow

Subjects will be administered varying levels of exhaust flow: 35, 23, 18, 13 and 8 L/s


Locations(1)

Brigham and Women's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07062770


Related Trials